Investor Relations and ASX Biosciences : Part of the Problem

In the last couple of weeks we have seen a couple of interesting movements between the corporate and investor relations world, a “new” arrival and an “old” departure. Firstly, in Prima Biomed’s (ASX :PRR) most recent investment letter we quietly learned of Stuart Roberts’ departure from Prima Biomed as Head of Investor Relations, and the appointment of…

Public Apology : Stuart Roberts

I’d like to state from the outset, that despite a deeply ingrained sense of Catholic guilt, I generally don’t apologise just for the sake of apology. When I apologise, I sincerely mean it – and upon reflection this weekend – I would like to sincerely apologise to Stuart Roberts for my last two posts. The style of my…

Good MAAAAAAWNIN’ Sydney!

Good maaaaaawning Stuart Roberts in Sydney, Let me start this email by asking you, Prima BioMed, a question. Are you optimistic about the state of the world at the moment, or pessimistic? Me, I’m pessimistic, indeed, I’ve been particularly pessimistic ever since I watched your stock rally on the basis of yesterday’s sensationalist drivel. I couldn’t…

More misleading guidance from Prima Biomed

Today Prima Biomed (ASX : PRR / NASDAQ : PBMD) announced that it had “received positive scientific advice” from the European Medicines Agency (EMA). Specifically, PRR claims that “after dialogue between Prima and the EMA, the Agency has now confirmed in writing its endorsement of the development program of IMP321 in metastatic breast cancer.” Amazing…!…

Prima Files a Patent

Prima has had an amazing couple of couple of weeks. A stratospheric stock adjustment that seems to have stuck (nice!). Some good visibility, no doubt, around ASCO time which is great. There remains an odd, slightly contrived echo of jubilation that CVac is an exciting outcome (I’ve already addressed this so I am not going to…

Ah Prima…

I’ve been waiting a long time for this day. You may not believe it, but I try to avoid just randomly commentating on companies, it’s always much nicer to have something to tie a post to. Something real-time and juicy. Yesterday’s announcement about Prima Biomed (ASX:PRR) truly got my Germanic juices flowing, my säfte fließen if…

No, I didn’t razz Stuart Roberts, but I wish I had…

About a dozen people forwarded me an email last week that was written by Stuart Roberts, Head of Investor Relations at Prima Biomed (ASX:PRR). It got a lot of airplay on various online forums so I consider it to be public domain. It is copied at the end of this post for your general entertainment.…